Eupraxia Pharmaceuticals Inc. (EPRX)
NASDAQ: EPRX · Real-Time Price · USD
5.40
+0.02 (0.35%)
Jul 16, 2025, 4:00 PM - Market closed

Eupraxia Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
1941121115828-
Upgrade
Market Cap Growth
4.85%0.65%90.50%111.19%--
Upgrade
Enterprise Value
19710296438-
Upgrade
Last Close Price
5.353.174.162.692.30-
Upgrade
Debt / Equity Ratio
0.000.0011.711.250.52-0.59
Upgrade
Quick Ratio
12.5910.741.016.0013.380.03
Upgrade
Current Ratio
13.0011.101.026.0813.490.05
Upgrade
Return on Equity (ROE)
-116.77%-157.31%-715.19%-178.04%--
Upgrade
Return on Assets (ROA)
-52.06%-61.14%-88.37%-52.20%-68.51%-59.25%
Upgrade
Return on Capital (ROIC)
-62.63%-78.03%-126.40%-58.41%-110.75%-
Upgrade
Buyback Yield / Dilution
-37.52%-40.52%-25.21%-55.45%-102.75%-0.01%
Upgrade
Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q